As demonstrated, the prevalence of HER2+ disease and triple-negative disease, the more aggressive biological subtypes of breast cancer, was 30.4% and 27.7%, respectively, in the Newfoundland and Labrador population. The gene discussed is ERBB2; the disease is breast cancer.